Comparison of Hounsfield Units and Vertebral Bone Quality Score for the Prediction of Time to Pathologic Fracture in Mobile Spine Metastases Treated With Radiotherapy.
作者信息
Chu Po-Jui, Yen Hung-Kuan, Huang Po-Hao, Hu Ming-Hsiao
机构信息
Department of Orthopedic Surgery, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
Department of Orthopedic Surgery, National Taiwan University Hospital, Taipei, Taiwan.
出版信息
Global Spine J. 2025 Mar 4:21925682251325173. doi: 10.1177/21925682251325173.
Abstract
摘要
相似文献
1
Comparison of Hounsfield Units and Vertebral Bone Quality Score for the Prediction of Time to Pathologic Fracture in Mobile Spine Metastases Treated With Radiotherapy.比较Hounsfield单位和椎体骨质量评分对接受放疗的活动脊柱转移瘤病理性骨折发生时间的预测价值。
Global Spine J. 2025 Mar 4:21925682251325173. doi: 10.1177/21925682251325173.
2
Comparison of Hounsfield units and vertebral bone quality score for the prediction of time to pathologic fracture in mobile spine metastases treated with radiotherapy.比较亨氏单位和椎体骨质量评分对放射治疗治疗的活动性脊柱转移瘤患者发生病理性骨折时间的预测价值。
J Neurosurg Spine. 2023 Oct 13;40(1):19-27. doi: 10.3171/2023.8.SPINE23420. Print 2024 Jan 1.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
Prediction of subsequent vertebral fracture after percutaneous vertebral augmentation using MRI-based vertebral bone quality and CT-based Hounsfield units: a retrospective cross-sectional study.使用基于MRI的椎体骨质量和基于CT的亨氏单位预测经皮椎体强化术后的后续椎体骨折：一项回顾性横断面研究。
Sci Rep. 2025 Jan 28;15(1):3524. doi: 10.1038/s41598-025-86721-5.
5
Do Hounsfield Units From Intraoperative CT Scans Correlate With Preoperative Values?术中 CT 扫描的 Hounsfield 单位与术前值相关吗？
Clin Orthop Relat Res. 2024 Oct 1;482(10):1885-1892. doi: 10.1097/CORR.0000000000003122. Epub 2024 May 9.
6
A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.一项关于恶性脊柱转移瘤的证据的系统回顾：自然病史和识别高风险椎体骨折和脊髓压迫患者的技术。
Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420.
7
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial.立体定向放射外科与常规放疗治疗脊柱局部转移瘤的比较：NRG 肿瘤学/RTOG 0631 随机临床试验的 3 期结果。
JAMA Oncol. 2023 Jun 1;9(6):800-807. doi: 10.1001/jamaoncol.2023.0356.
8
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗？
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
9
Osteoporosis screening and major osteoporotic fracture prediction by cranial computed tomography-derived Hounsfield units: a multi-center study on opportunistic osteoporosis screening.通过头颅计算机断层扫描得出的亨氏单位进行骨质疏松症筛查及主要骨质疏松性骨折预测：一项机会性骨质疏松症筛查的多中心研究
Ann Med. 2025 Dec;57(1):2554930. doi: 10.1080/07853890.2025.2554930. Epub 2025 Sep 5.
10
Longitudinal Radiographical Changes Following Minimally Invasive Ablation and Cementoplasty of Osteolytic Vertebral Metastases: A Retrospective Study.溶骨性椎体转移瘤微创消融与骨水泥成形术后的纵向影像学变化：一项回顾性研究
HSS J. 2025 Jun 26:15563316251346485. doi: 10.1177/15563316251346485.
本文引用的文献
1
Antiresorptive Medications Prior to Stereotactic Body Radiotherapy for Spinal Metastasis are Associated with Reduced Incidence of Vertebral Body Compression Fracture.脊柱转移瘤立体定向体部放疗前使用抗骨吸收药物与椎体压缩骨折发生率降低相关。
Global Spine J. 2024 Jul;14(6):1778-1785. doi: 10.1177/21925682231156394. Epub 2023 Feb 7.
2
Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials.比较地舒单抗和唑来膦酸治疗实体瘤和多发性骨髓瘤伴骨转移：基于随机对照试验的系统评价和荟萃分析。
J Orthop Surg Res. 2021 Jun 22;16(1):400. doi: 10.1186/s13018-021-02554-8.
3
Fracture Prevention with Zoledronate in Older Women with Osteopenia.唑来膦酸治疗老年妇女骨质疏松症性骨折的预防作用。
N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082. Epub 2018 Oct 1.
4
Warning of an increased risk of vertebral fracture after stopping denosumab.停用地诺单抗后椎体骨折风险增加的警告。
CMAJ. 2018 Apr 23;190(16):E485-E486. doi: 10.1503/cmaj.180115.
5
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension.地舒单抗停药后发生的椎体骨折：一项 FREEDOM 随机安慰剂对照试验及其延伸的事后分析。
J Bone Miner Res. 2018 Feb;33(2):190-198. doi: 10.1002/jbmr.3337. Epub 2017 Nov 22.
6
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.10 年地舒单抗治疗绝经后骨质疏松症妇女：来自 3 期随机 FREEDOM 试验和开放标签扩展的结果。
Lancet Diabetes Endocrinol. 2017 Jul;5(7):513-523. doi: 10.1016/S2213-8587(17)30138-9. Epub 2017 May 22.
7
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors.在一项针对晚期癌症患者的地舒单抗与唑来膦酸的随机 3 期研究中延迟骨骼相关事件：来自实体瘤患者的数据分析。
Support Care Cancer. 2014 Mar;22(3):679-87. doi: 10.1007/s00520-013-2022-1. Epub 2013 Oct 26.
Zotero 插件